Apolipoprotein E ε4 allele frequency in demented and cognitively impaired patients with and without cerebrovascular disease

Journal of the Neurological Sciences

Volumn 203-204, Issue , 2002, Pages 177-181

  Traykov, Latchezar ^a,b   Rigaud, Anne Sophie ^c   Baudic, Sophie ^a   Smagghe, Alain ^d   Boller, François ^a   Forette, Françoise ^c  

^a INSERM   (France)

^b UNIVERSITY HOSPITAL ALEXANDROVSKA   (Bulgaria)

^c Paris Descartes University   (France)

^d Hopital Notre Dame de Bonne Secours   (France)

Author keywords

Alzheimer's disease; Apolipoprotein E (ApoE); Cerebrovascular disease; Mild cognitive impairment; Mixed dementia; Vascular dementia

Indexed keywords

APOLIPOPROTEIN E;

ADULT; AGED; ALLELE; ALZHEIMER DISEASE; CEREBROVASCULAR DISEASE; COGNITIVE DEFECT; COMPARATIVE STUDY; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE FREQUENCY; HUMAN; MAJOR CLINICAL STUDY; MALE; MOLECULAR PHYLOGENY; MULTIINFARCT DEMENTIA; PHENOTYPE; PRIORITY JOURNAL; RISK FACTOR; VASCULAR DISEASE; ARTICLE; CLINICAL TRIAL; GENETICS; PSYCHOLOGICAL ASPECT; PSYCHOLOGICAL RATING SCALE;

AGED; AGED, 80 AND OVER; ALLELES; ALZHEIMER DISEASE; APOLIPOPROTEINS E; COGNITION DISORDERS; DEMENTIA, VASCULAR; FEMALE; GENE FREQUENCY; HUMANS; MALE; PHENOTYPE; PSYCHIATRIC STATUS RATING SCALES;

EID: 0037111448     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(02)00287-3     Document Type: Conference Paper

References (21)

1. Roses A., Strittmatter W., Saunders A., Schmechel D., Pericak-Vance M. Apolipoprotein E and Alzheimer's disease: state of the field after two years. Roses A., Weisgraber K., Christen Y. Apolipoprotein E and Alzheimer's disease. 1996;1-10 Springer, Berlin.
2. Noguchi S., Murakami K., Yamada N. Apolipoprotein-E genotype and Alzheimer's disease. Lancet. 342:1993;737.
3. Treves T.A., Bornstein N.M., Chapman J., Klimovitzki S., Verchovsky R., Asherov A.et al. APOE-ε4 in patients with Alzheimer disease and vascular dementia. Alzheimer Dis. Assoc. Disord. 10:1996;189-191.
4. Davignon J., Gregg R.E., Sing C.F. Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis. 8:1988;1-12.
5. Eichner J.E., Kuller L.H., Orchard T.J., Grandits G.A., McCallum L.M., Ferrell R.E.et al. Relation of apolipoprotein E phenotype to myocardial infarction and mortality from coronary artery disease. Am. J. Cardiol. 71:1993;160-165.
6. Kuusisto J., Mykkanen L., Kervinen K., Kesaniemi Y.A., Laakso M. Apolipoprotein E4 phenotype is not an important risk factor for coronary heart disease or stroke in elderly subjects. Arterioscler. Thromb. Vasc. Biol. 15:1995;1280-1286.
7. Saunders A.M., Roses A.D. Apolipoprotein E allele frequency, ischemic cerebrovascular disease, and Alzheimer's disease. Stroke. 24:1993;1416. [Letter].
8. Kawamata J., Tanaka S., Shimohama S., Uede K., Kimura J. Apolipoprotein E polymorphism in Japanese patients with Alzheimer's disease or vascular dementia. J. Neurol. Neurosurg. Psychiatry. 57:1994;1414-1416.
9. Pirttilä T., Lehtimäki T., Rinne J., Mattila K., Frey H., Nikkari T. The frequency of apolipoprotein E4 allele is not increased in patients with probable vascular dementia. Acta Neurol. Scand. 93:1996;352-354.
10. Traykov L., Rigaud A.S., Caputo L., Couderc R., Coste J., Michot J.L.et al. Apolipoprotein E phenotypes in demented and cognitively impaired patients with and without cerebrovascular disease. Eur. J. Neurol. 6:1999;415-421.
11. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders. 4th Ed. 1994; American Psychiatric Association, Washington, DC.
12. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 34:1984;939-944.
13. Roman G.C., Tatemichi T.K., Erkinjuntti T., Cummings J.L., Masdeu J.C., Garcia J.H.et al. Vascular dementia: diagnostic criteria for research studies (report of the NINDS-AIREN International Workshop). Neurology. 43:1993;250-260.
14. Petersen R.C., Smith G.E., Ivnik R.J., Tangalos E.G., Schaid D.J., Thibodeau S.N.et al. Apolipoprotein E status as a predictor of the development of Alzheimer's disease in memory-impaired individuals. JAMA. 273:1995;1274-1278.
15. Bailleul S., Couderc R., Landais V., Lefevre G., Raichvarg D., Etienne J. Direct phenotyping of human Apolipoprotein E in plasma: application to population frequency distribution in Paris (France). Hum. Hered. 43:1993;159-165.
16. Harrington C.R., Louwagie J., Rossau E., Vanmechelen R.H., Perry E.K., Xuereb J.H.et al. Influence of apolipoprotein E genotype on senile dementia of the Alzheimer and Lewy body types. Am. J. Pathol. 145:1994;1472-1484.
17. Bowler J.V., Steenhuis R., Hachinski V. Conceptual background to vascular cognitive impairment. Alzheimer Dis. Assoc. Disord. 13(Suppl. 3):1999;30-37.
18. Chui H.C., Victoroff J.I., Margolin D., Jagust W., Shankle R., Katzman R. Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers. Neurology. 42:1992;473-480.
19. Schmidt R., Schmidt H., Fazekas F., Schumacher M., Niederkorn K., Kapeller P.et al. Apolipoprotein E polymorphism and silent microangiopathy-related cerebral damage: results of the Austrian Stroke Prevention Study. Stroke. 28:1997;951-956.
20. Bétard C., Robitaille Y., Gee M., Tiberghien D., Larrivee D., Roy P.et al. Apo E allele frequencies in Alzheimer's disease, Lewy body dementia, Alzheimer's disease with cerebrovascular disease and vascular dementia. NeuroReport. 5:1994;1893-1896.
21. Dickson D.W., Roy N., Graff-Radford D., Perez-Tur J., Hardy J., Pearl G.et al. Apolipoprotein-E genotype influences amyloid deposition and limbic neurofibrillary degeneration, but not Lewy body or vascular pathologies in postmortem brains. Neurology. 52(Suppl. 2):1999;562-563.